KDM1A inhibitors for the treatment of disease Grant US-11932629-B2 United States of America 19 Mar 2024
Compositions comprising a bacterial strain of the genus Megasphera and uses thereof Grant US-11779613-B2 United States of America 10 Oct 2023
KDM1A inhibitors for the treatment of disease Grant US-11773068-B2 United States of America 03 Oct 2023
METHOD TO DETECT RNA BIOMARKERS Application WO-2023094365-A1 World Intellectual Property Organisation (WIPO) 01 Jun 2023
KDM1A inhibitors for the treatment of disease Grant US-11655226-B2 United States of America 23 May 2023
KDM1A inhibitors for the treatment of disease Grant US-11578059-B2 United States of America 14 Feb 2023
Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic… Grant US-11572408-B2 United States of America 07 Feb 2023
HDAC6 INHIBITORS FOR USE IN THE TREATMENT OF DILATED CARDIOMYOPATHY Application WO-2022226388-A1 World Intellectual Property Organisation (WIPO) 27 Oct 2022
Valproic acid for the treatment or prevention of pathological conditions associated with… Grant US-11400064-B2 United States of America 02 Aug 2022
Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof Grant US-11395808-B2 United States of America 26 Jul 2022
Methods and processes for the preparation of KDM1A inhibitors Grant US-11390590-B2 United States of America 19 Jul 2022
KDM1A inhibitors for the treatment of disease Grant US-11230534-B2 United States of America 25 Jan 2022
Compositions comprising a bacterial strain of the genus Megasphera and uses thereof Grant US-11007233-B2 United States of America 18 May 2021
KDM1A inhibitors for the treatment of disease Grant US-10882835-B2 United States of America 05 Jan 2021
Physically and chemically stable oral suspensions of givinostat Grant US-10688047-B2 United States of America 23 Jun 2020
KDM1A inhibitors for the treatment of disease Grant US-10519118-B2 United States of America 31 Dec 2019
KDM1A inhibitors for the treatment of disease Grant US-10370346-B2 United States of America 06 Aug 2019
Valproic acid for the treatment or prevention of pathological conditions associated with… Application US-10111845-B2 United States of America 30 Oct 2018
LYSINE-SPECIFIC HISTONE DEMETHYLASE AS A NOVEL THERAPEUTIC TARGET IN MYELOPROLIFERATIVE… Application WO-2017079753-A1 World Intellectual Property Organisation (WIPO) 11 May 2017
Use of histone deacetylase inhibitors for the care of philadelphia-negative… Grant US-9522127-B2 United States of America 20 Dec 2016
METHODS FOR THE IDENTIFICATION AND CHARACTERIZATION OF HDAC INTERACTING COMPOUNDS Application US-20130071854-A1 United States of America 21 Mar 2013
Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments Application US-8227515-B2 United States of America 24 Jul 2012
Method for treating Philadelphia-negative myeloproliferative syndromes Grant US-8217079-B2 United States of America 10 Jul 2012